The Business Research Company’s report on the Stereotactic Surgery Devices Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the stereotactic surgery devices market further?
The increasing number of Parkinson’s disease and epilepsy are expected to boost the growth of the stereotactic surgical device market going forward. Parkinson’s disease is a neurodegenerative illness that causes involuntary shaking, sluggish movement, and stiff, inflexible muscles, whereas epilepsy is a neurological ailment that affects the brain and renders patients more susceptible to experiencing recurring, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, and psychiatry, as well as Parkinson’s disease. For instance, as per the study revealed by the Parkinson’s Foundation, a New York-based national nonprofit organization, in 2022, in the United States, over 90,000 people will be diagnosed with Parkinson’s disease each year. This is a 50% rise from the previously expected yearly rate of 60,000 diagnoses. Parkinson’s disease (PD) affects almost a million people in the United States. By 2030, to increase to 1.2 million. Therefore, increasing cases of Parkinson’s disease and epilepsy are driving the growth of the stereotactic surgical device market.
Access Your Free Sample of the Global Stereotactic Surgery Devices Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp
What are the key factors influencing the forecasted market size of the stereotactic surgery devices industry?
The stereotactic surgery devices market size has grown steadily in recent years. It will grow from$21.8 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to shift towards minimally invasive procedures, integration of robotics and automation, increased demand for precision and accuracy, improved safety profiles
The stereotactic surgery devices market size is expected to see strong growth in the next few years. It will grow to “$28.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising cases of cancer, ai and machine learning integration, expansion to new medical specialties, rise in geriatric population, customization and personalization in treatments. Major trends in the forecast period include precision and accuracy improvement, miniaturization of devices, robotics and automation, personalized treatment approaches, expanded applications and procedures.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10495&type=smp
Who are the leading competitors in the stereotactic surgery devices market?
Major companies operating in the stereotactic surgery devices market include Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.
Which emerging trends are set to transform the stereotactic surgery devices market landscape?
Technological advancements have emerged as the key trend gaining popularity in the stereotactic surgical device market. Major companies operating in the stereotactic surgical device market are developing innovative technologies to strengthen their position in the market. For instance, in May 2023, Brainlab, a Germany-based medical technology company has launched a new product called ExacTrac Dynamic Surface, which is a surface guided radiation therapy (SGRT) patient tracking and positioning system. The system offers high-speed thermal surface tracking technology combined with an update of ExacTrac X-ray monitoring, which increases versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system emits a structured blue light pattern onto the patient surface that is acquired by two 3D cameras, and each surface point is augmented with a thermal signature, which is registered by the third in-unit camera.
How do different geographies compare in terms of market share and growth potential in the stereotactic surgery devices market?
North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report
Which major segments of the stereotactic surgery devices market are experiencing the fastest growth?
The stereotactic surgery devices market covered in this report is segmented –
1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories
Subsegments:
1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon
2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC
3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems
4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10495
How is the stereotactic surgery devices market defined, and what are its core characteristics?
A stereotactic surgical device is a technology that employs a set of three coordinates to precisely locate brain parts while the head is in a fixed position. It is used in stereotactic surgery to implant things into the brain, such as medications or hormones.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
